Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Prepaid Assets (2019 - 2025)

Pliant Therapeutics (PLRX) has disclosed Prepaid Assets for 7 consecutive years, with $4.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 31.74% to $4.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.5 million, a 31.74% decrease, with the full-year FY2025 number at $4.5 million, down 31.74% from a year prior.
  • Prepaid Assets was $4.5 million for Q4 2025 at Pliant Therapeutics, up from $3.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $8.9 million in Q2 2023 to a low of $3.8 million in Q3 2025.
  • A 5-year average of $5.4 million and a median of $5.2 million in 2021 define the central range for Prepaid Assets.
  • Biggest YoY gain for Prepaid Assets was 10.25% in 2021; the steepest drop was 40.96% in 2021.
  • Pliant Therapeutics' Prepaid Assets stood at $5.8 million in 2021, then fell by 28.87% to $4.2 million in 2022, then surged by 113.63% to $8.9 million in 2023, then fell by 26.39% to $6.5 million in 2024, then crashed by 31.74% to $4.5 million in 2025.
  • Per Business Quant, the three most recent readings for PLRX's Prepaid Assets are $4.5 million (Q4 2025), $3.8 million (Q3 2025), and $5.5 million (Q1 2025).